PraxisUnico is pleased to be supporting Biotech and Money London 2016, a two-day congress providing the education, strategies and solutions life science companies need to enable more effective funding, investment, business planning and partnering within their businesses on Feb 2-3 2016.
At its heart is the mission to help build linkages and business opportunities for UK life science companies, capital and partners. It's where life science meets money, investors meet deal flow and industry promote strategic collaborations.
Of particular interest to PraxisUnico members are the sessions on "Is technology transfer and translation working in life sciences? Unravelling reality from myth", at which PraxisUnico Board members Malcolm Skingle, Tony Hickson and Training Committee member Adam Stoten are speaking.
Other key speakers at the event include:
- Sir Chris Evans OBE, Chairman, Excalibur Group
- Jim Mellon, Serial Entrepreneur and Founder, Mann Bioinvest
- Dennis Purcell, Founder, Aisling Capital
- Andy Smith, CIO, Mann Bioinvest
- Darrin Disley, CEO, Horizon Discovery
- Peter George, CEO, Clinigen
- Russ Cummings, CEO, Imperial Innovations
- Nigel Pitchford, CIO, Imperial Innovations
- Peter Dines, Head of Life Sciences, Mercia Fund Management
- Cathrin Petty, Head of European Healthcare Banking, JP Morgan
- Robert Tansley, Investment Director, Cambridge Innovation Capital
Download the brochure for the full agenda and speaker line-up.
New featured for 2016 include:
- Launch of our bold new Report on Healthcare Investment in the UK - commissioned by over 25 UK CEO's, and backed by EY, Neil Woodford, the BIA, Imperial Innovations and many more
- Brand new Pharma focus - with top BD heads Luigi de la Corte and Shaun Grady of GSK and Astrazeneca already confirmed in this new focus day
- Our exclusive HealthEx CEO forum for publicly listed life science CEO’s and CFO's
- Exclusive presentations from the 'UK's One's to Watch' - showcasing the finest innovative life science companies coming out of the UK